Wangzhi Li
Stock Analyst at Ladenburg Thalmann
(2.77)
# 1,892
Out of 4,944 analysts
3
Total ratings
66.67%
Success rate
27.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Wangzhi Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Initiates: Buy | $23 | $149.36 | -84.60% | 1 | Oct 18, 2017 | |
| LPTX Leap Therapeutics | Initiates: Buy | $180 | $0.34 | +52,997.35% | 1 | Mar 7, 2017 | |
| CLRB Cellectar Biosciences | Initiates: Buy | $8,100 | $4.42 | +183,157.92% | 1 | Dec 21, 2016 |
Krystal Biotech
Oct 18, 2017
Initiates: Buy
Price Target: $23
Current: $149.36
Upside: -84.60%
Leap Therapeutics
Mar 7, 2017
Initiates: Buy
Price Target: $180
Current: $0.34
Upside: +52,997.35%
Cellectar Biosciences
Dec 21, 2016
Initiates: Buy
Price Target: $8,100
Current: $4.42
Upside: +183,157.92%